Tuesday, May 28, 2024
Arnold & Porter Webinar
On May 16, 2024, the Department of Justice issued a Notice of Proposed Rulemaking (NPRM) and Office of Legal Counsel opinion proposing rescheduling cannabis from Schedule I to Schedule III. The NPRM acted on a recommendation by the Department of Health and Human Services and Food and Drug Administration (FDA) to move cannabis to Schedule III. If finalized, this rule would mark a significant change in the regulatory status of cannabis, which could have important financial and other implications for the growing cannabis industry and its investors.
Please join Howard Sklamberg, Elizabeth Trentacost, James Joseph, and Evelina Norwinski in a detailed discussion of this proposal to reschedule. They will provide background on the rescheduling process, summarize the NPRM and its reasoning, discuss implications for FDA regulation of cannabis and cannabis research, and outline the next steps in the rulemaking and judicial process. They will also discuss the possible tax implications for the cannabis industry and how banking and other laws continue to regulate cannabis.
To view the full article, click here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.